Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuronavigation-based glycerol injection for trigeminal neuralgia
NCT02624661Phase 2Terminated
- Sponsor
- Norwegian University of Science and Technology
- Start
- May 2016
- Primary completion
- Jan 2019
- Modality
- Small Molecules, Implantable Devices
- Countries
- 1
01
Overview
Phase 2, open-label trial of glycerol in trigeminal neuralgia (TN), sponsored by Norwegian University of Science and Technology. Primary endpoint: Number of adverse events at 12 weeks. Started May 2016; status: terminated.
02
Drugs
glycerol
03
Conditions
trigeminal neuralgia (TN)
Beyond the preview
Go deeper on NCT02624661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02624661.